We are working with Takeda Pharmaceutical Company Limited (« Takeda ») to achieve genetically defined goals for the treatment of other NSZ diseases, including Alzheimer`s disease and Parkinson`s disease. Under the agreement, we can work with Takeda on up to six preclinical programs simultaneously for a period of four years. Takeda is allowed to grant only several preclinical programs on our part during our lifetime. Quarterly payments. At the end of each quarter, the developer registers a request from Aero for revenue and cost sharing purposes. This type of consideration is not within the scope of a subject or a similar subject; Therefore, the developer should use a choice of accounting and valuation policy to assess each part of the debt based on the nature of the associated activity. For example, the portion of the debt related to the developer`s share of revenue would be treated as an increase in turnover with cooperation, while the part of the debt collector would be a reduction in revenue costs. As of September 30, 2018, the company had generated $8.8 million in revenue as a collaborative revenue in the company`s consolidated operating account and a significant loss under the Pfizer collaboration agreement. In the three and nine months ended September 30, 2018, the company generated revenues of $1.0 million and $3.9 million, respectively, under the Pfizer Cooperation Agreement.
The total transaction price attributed to the company`s partially dissatisfied performance obligations and recorded in latent revenues as of September 30, 2018 is $9.7 million, of which $6.7 million is included in short-term commitments. The Company expects this amount to be determined by etp hours. 19 months from September 2018. Collaborative agreements come in all forms and sizes. Participants in a collaborative agreement generally agree to share the revenues and costs of the agreement. An example is a partnership for the realization of scientific research for the development of a new medical device. Another is a joint venture to produce and distribute a documentary. For more information on accounting for collaborative revenues, see Note 4, « Cooperation Agreements » on the extent to which we invest or invest in companies, products and technologies, including licensing or collaboration agreements for product applicants.